1,941
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A smartwatch sphygmomanometer-based model for predicting short-term new-onset hypertension in individuals with high-normal blood pressure: a cohort study

ORCID Icon, , , , , , , , , & show all
Article: 2304023 | Received 27 Sep 2023, Accepted 03 Jan 2024, Published online: 12 Feb 2024

References

  • Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, Gregg EW, Bennett JE, Solomon B, Singleton RK, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021;398(10304):957–8. doi:10.1016/S0140-6736(21)01330-1.
  • Diseases NCfC, Association CMD, Committee CMDAH, cardiology CSo, Committee AomeatTsH. Practice guidelines of hypertension in China. Chinese J Cardiol. 2022, 50, 1050–95.
  • Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):e13–115. doi:10.1161/HYP.0000000000000065.
  • Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. doi:10.1093/eurheartj/ehy339.
  • Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785–802. doi:10.1038/s41569-021-00559-8.
  • Julius S, Kaciroti N, Egan BM, Nesbitt S, Michelson EL. TROPHY study: outcomes based on the seventh report of the joint national committee on hypertension definition of hypertension. J Am Soc Hypertens. 2008;2(1):39–43. doi:10.1016/j.jash.2007.07.005.
  • Mazza A, Schiavon L, Rigatelli G, Torin G, Lenti S. The effects of a new generation of nutraceutical compounds on lipid profile and glycaemia in subjects with pre-hypertension. High Blood Press Cardiovasc Prev. 2019;26(4):345–50. doi:10.1007/s40292-019-00332-6.
  • Hanssen H, Boardman H, Deiseroth A, Moholdt T, Simonenko M, Kränkel N, Niebauer J, Tiberi M, Abreu A, Solberg EE, et al. Personalized exercise prescription in the prevention and treatment of arterial hypertension: a consensus document from the European Association of Preventive Cardiology (EAPC) and the ESC council on hypertension. Eur J Prev Cardiol. 2022;29(1):205–15. doi:10.1093/eurjpc/zwaa141.
  • Krishnaswami A, Beavers C, Dorsch MP, Dodson JA, Masterson Creber R, Kitsiou S, Goyal P, Maurer MS, Wenger NK, Croy DS, et al. Gerotechnology for older adults with cardiovascular diseases: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76(22):2650–70. doi:10.1016/j.jacc.2020.09.606.
  • Zhang W, Zhou YN, Zhou Y, Wang JG. Validation of the watch-type HUAWEI WATCH D oscillometric wrist blood pressure monitor in adult Chinese. Blood Press Monit. 2022;27(5):353–56. doi:10.1097/MBP.0000000000000608.
  • Yi L, Lv ZH, Hu SY, Liu Y-Q, Yan J-B, Zhang H, Li H-B, Chen Q, Li Y-Y, Jiang Y-F, et al. Validating the accuracy of a multifunctional smartwatch sphygmomanometer to monitor blood pressure. J Geriatr Cardiol. 2022;19(11):843–52. doi:10.11909/j.issn.1671-5411.2022.11.004.
  • Stergiou GS, Palatini P, Parati G, O’Brien E, Januszewicz A, Lurbe E, Persu A, Mancia G, Kreutz R. 2021 European society of hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293–302. doi:10.1097/HJH.0000000000002843.
  • Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–9. doi:10.1158/1078-0432.CCR-04-0713.
  • E. F, Jr. H. Rms: Regression Modeling Strategies. R Package version 3.4-0.
  • Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, Mokdad AH , Moradi-Lakeh M, Naghavi M, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017;377 (1): 13–27. doi:10.1056/NEJMoa1614362.
  • Zhang X, Zhang M, Zhao Z, Huang Z, Deng Q, Li Y, Pan A, Li C, Chen Z, Zhou M, et al. Geographic variation in prevalence of adult obesity in China: results from the 2013–2014 national chronic disease and risk factor surveillance. Ann Intern Med. 2020;172(4):291–93. doi:10.7326/M19-0477.
  • Collaborators GRF, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, Abd-Allah F, Abdelalim A, Abdollahi M, Abdollahpour I. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1223–49. doi:10.1016/S0140-6736(20)30752-2.
  • Roth GA, Nguyen G, Forouzanfar MH, Mokdad AH, Naghavi M, Murray CJ. Estimates of global and regional premature cardiovascular mortality in 2025. Circulation. 2015;132(13):1270–82. doi:10.1161/CIRCULATIONAHA.115.016021.
  • Allegrante JP, Wells MT, Peterson JC. Interventions to support behavioral self-management of chronic diseases. Annu Rev Public Health. 2019;40(1):127–46. doi:10.1146/annurev-publhealth-040218-044008.
  • Reynolds R, Dennis S, Hasan I, Slewa J, Chen W, Tian D, Bobba S, Zwar N. A systematic review of chronic disease management interventions in primary care. BMC Fam Pract. 2018;19(1):11. doi:10.1186/s12875-017-0692-3.
  • Alessa T, Hawley MS, Hock ES, de Witte L. Smartphone apps to support self-management of hypertension: review and content analysis. JMIR mHealth Uhealth. 2019;7(5):e13645. doi:10.2196/13645.
  • Coughlin SS, Prochaska JJ, Williams LB, Besenyi G, Heboyan V, Goggans S, Yoo W, De Leo G. Patient web portals, disease management, and primary prevention. Risk Manag Healthc Policy. 2017;10:33–40. doi:10.2147/RMHP.S130431.
  • Xiong S, Berkhouse H, Schooler M, Pu W, Sun A, Gong E, Yan LL. Effectiveness of mHealth interventions in improving medication adherence among people with hypertension: a systematic review. Curr Hypertens Rep. 2018;20(10):86. doi:10.1007/s11906-018-0886-7.
  • McLean G, Band R, Saunderson K, Hanlon P, Murray E, Little P, McManus RJ, Yardley L, Mair FS. Digital interventions to promote self-management in adults with hypertension systematic review and meta-analysis. J Hypertens. 2016;34(4):600–12. doi:10.1097/HJH.0000000000000859.
  • Rubinstein A, Miranda JJ, Beratarrechea A, Diez-Canseco F, Kanter R, Gutierrez L, Bernabé-Ortiz A, Irazola V, Fernandez A, Letona P, et al. Effectiveness of an mHealth intervention to improve the cardiometabolic profile of people with prehypertension in low-resource urban settings in Latin America: a randomised controlled trial. Lancet Diabetes Endocrinol. 2016;4(1):52–63. doi:10.1016/S2213-8587(15)00381-2.
  • Kario K, Nomura A, Harada N, Okura A, Nakagawa K, Tanigawa T, Hida E. Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial. Eur Heart J. 2021;42:4111–22. doi:10.1093/eurheartj/ehab559.